The clinical efficacy of a single afternoon dose of levodopa methyl ester: A double-blind cross-over study versus placebo

F. Stocchi, L. Barbato, L. Bramante, A. Bonamartini, S. Ruggieri

Research output: Contribution to journalArticle

18 Citations (Scopus)

Abstract

Levodopa methyl ester (LDME) is a highly water soluble derivative produced by esterification of the carboxilic acid moiety of the L-Dopa molecule that is rapidly hydrolyzed to L-Dopa and can be administered orally in an easily dosable liquid form. In this study the relative efficacy and tolerability of a single dose of an oral solution of 250 mg of LDME was compared to that of placebo in reversing afternoon off period. A controlled double-blind cross-over study versus placebo had previously been carried out in 25 idiopathic parkinsonian patients with predictable fluctuations in motor performances. The study design stipulated the sequential administration of LDME and placebo in group A and placebo and LDME in group B on two consecutive days. All patients turned 'on' with LDME and none with placebo solution. The mean latency to 'on' was 25.3 ± 13.5 min for the A group and 27.6 ± 3.9 min for group B and the 'on' duration was 147.7 ± 50.3 min and 163.3 ± 39.3 min for the A and B groups respectively. Five patients suffering from drug resistant 'off' phenomena turned 'on' with LDME solution showing a mean latency to 'on' of 31.4 ± 6.2 min.

Original languageEnglish
Pages (from-to)259-264
Number of pages6
JournalFunctional Neurology
Volume9
Issue number5
Publication statusPublished - 1994

Fingerprint

Cross-Over Studies
Placebos
Levodopa
Esterification
levodopa methyl ester
Acids
Water
Pharmaceutical Preparations

Keywords

  • Fluctuations
  • Levodopa
  • Levodopa methyl ester
  • Motor
  • Parkinson's disease

ASJC Scopus subject areas

  • Clinical Neurology
  • Neuroscience(all)

Cite this

The clinical efficacy of a single afternoon dose of levodopa methyl ester : A double-blind cross-over study versus placebo. / Stocchi, F.; Barbato, L.; Bramante, L.; Bonamartini, A.; Ruggieri, S.

In: Functional Neurology, Vol. 9, No. 5, 1994, p. 259-264.

Research output: Contribution to journalArticle

Stocchi, F. ; Barbato, L. ; Bramante, L. ; Bonamartini, A. ; Ruggieri, S. / The clinical efficacy of a single afternoon dose of levodopa methyl ester : A double-blind cross-over study versus placebo. In: Functional Neurology. 1994 ; Vol. 9, No. 5. pp. 259-264.
@article{4e1fea67946247c98aa37cb877b03e1e,
title = "The clinical efficacy of a single afternoon dose of levodopa methyl ester: A double-blind cross-over study versus placebo",
abstract = "Levodopa methyl ester (LDME) is a highly water soluble derivative produced by esterification of the carboxilic acid moiety of the L-Dopa molecule that is rapidly hydrolyzed to L-Dopa and can be administered orally in an easily dosable liquid form. In this study the relative efficacy and tolerability of a single dose of an oral solution of 250 mg of LDME was compared to that of placebo in reversing afternoon off period. A controlled double-blind cross-over study versus placebo had previously been carried out in 25 idiopathic parkinsonian patients with predictable fluctuations in motor performances. The study design stipulated the sequential administration of LDME and placebo in group A and placebo and LDME in group B on two consecutive days. All patients turned 'on' with LDME and none with placebo solution. The mean latency to 'on' was 25.3 ± 13.5 min for the A group and 27.6 ± 3.9 min for group B and the 'on' duration was 147.7 ± 50.3 min and 163.3 ± 39.3 min for the A and B groups respectively. Five patients suffering from drug resistant 'off' phenomena turned 'on' with LDME solution showing a mean latency to 'on' of 31.4 ± 6.2 min.",
keywords = "Fluctuations, Levodopa, Levodopa methyl ester, Motor, Parkinson's disease",
author = "F. Stocchi and L. Barbato and L. Bramante and A. Bonamartini and S. Ruggieri",
year = "1994",
language = "English",
volume = "9",
pages = "259--264",
journal = "Functional Neurology",
issn = "0393-5264",
publisher = "CIC Edizioni Internazionali s.r.l.",
number = "5",

}

TY - JOUR

T1 - The clinical efficacy of a single afternoon dose of levodopa methyl ester

T2 - A double-blind cross-over study versus placebo

AU - Stocchi, F.

AU - Barbato, L.

AU - Bramante, L.

AU - Bonamartini, A.

AU - Ruggieri, S.

PY - 1994

Y1 - 1994

N2 - Levodopa methyl ester (LDME) is a highly water soluble derivative produced by esterification of the carboxilic acid moiety of the L-Dopa molecule that is rapidly hydrolyzed to L-Dopa and can be administered orally in an easily dosable liquid form. In this study the relative efficacy and tolerability of a single dose of an oral solution of 250 mg of LDME was compared to that of placebo in reversing afternoon off period. A controlled double-blind cross-over study versus placebo had previously been carried out in 25 idiopathic parkinsonian patients with predictable fluctuations in motor performances. The study design stipulated the sequential administration of LDME and placebo in group A and placebo and LDME in group B on two consecutive days. All patients turned 'on' with LDME and none with placebo solution. The mean latency to 'on' was 25.3 ± 13.5 min for the A group and 27.6 ± 3.9 min for group B and the 'on' duration was 147.7 ± 50.3 min and 163.3 ± 39.3 min for the A and B groups respectively. Five patients suffering from drug resistant 'off' phenomena turned 'on' with LDME solution showing a mean latency to 'on' of 31.4 ± 6.2 min.

AB - Levodopa methyl ester (LDME) is a highly water soluble derivative produced by esterification of the carboxilic acid moiety of the L-Dopa molecule that is rapidly hydrolyzed to L-Dopa and can be administered orally in an easily dosable liquid form. In this study the relative efficacy and tolerability of a single dose of an oral solution of 250 mg of LDME was compared to that of placebo in reversing afternoon off period. A controlled double-blind cross-over study versus placebo had previously been carried out in 25 idiopathic parkinsonian patients with predictable fluctuations in motor performances. The study design stipulated the sequential administration of LDME and placebo in group A and placebo and LDME in group B on two consecutive days. All patients turned 'on' with LDME and none with placebo solution. The mean latency to 'on' was 25.3 ± 13.5 min for the A group and 27.6 ± 3.9 min for group B and the 'on' duration was 147.7 ± 50.3 min and 163.3 ± 39.3 min for the A and B groups respectively. Five patients suffering from drug resistant 'off' phenomena turned 'on' with LDME solution showing a mean latency to 'on' of 31.4 ± 6.2 min.

KW - Fluctuations

KW - Levodopa

KW - Levodopa methyl ester

KW - Motor

KW - Parkinson's disease

UR - http://www.scopus.com/inward/record.url?scp=0028569771&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0028569771&partnerID=8YFLogxK

M3 - Article

C2 - 7750809

AN - SCOPUS:0028569771

VL - 9

SP - 259

EP - 264

JO - Functional Neurology

JF - Functional Neurology

SN - 0393-5264

IS - 5

ER -